Roche’s Spark takeover looks even more distant as FTC review delays again
admin 26th April 2019 Uncategorised 0Just days after Roche CEO Severin Schwan said the $4.8 billion buyout of Spark Therapeutics will close by June despite a recent delay, the company is extending its tender offer even further. More: Roche’s Spark takeover looks even more distant
read more